CIF130 inhibits cell cycle progression
US6589745B2 · kind B2 · utility
3Cited by
1References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 15, 2002 |
| Grant date | Jul 8, 2003 |
| Priority date | — |
| Expiry date | May 15, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A human gene termed CIF130 and its expression products can alter the spatial or temporal patterns of mitosis or cell cycle progression of a human cell. Methods of treating disorders involving alterations in the regulation of mitosis or cell cycle progression utilize the gene and its expression product. Genes whose expression is dependent upon CIF130 expression can be identified.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.